Medical Condition News

RSS

Health Affairs assesses real-world lifestyle interventions to help prevent diabetes

An Emory University study published in the January issue of Health Affairs assesses real-world lifestyle interventions to help delay or prevent the costly chronic disease that affects nearly 26 million Americans.

11 Jan 2012

Erlotinib better for treatment of non-small cell lung cancers

Researchers at Johns Hopkins have shown that DNA changes in a gene that drives the growth of a form of lung cancer can make the cancer's cells resistant to cancer drugs.

11 Jan 2012

Damon Runyon Cancer Research Foundation names 18 new Fellows

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 18 new Damon Runyon Fellows at its fall Fellowship Award Committee review.

11 Jan 2012

Precise diagnostic algorithm for fibrosis in HCV patients reduces need for liver biopsy

A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy.

11 Jan 2012

Disruption of circadian rhythms cause accelerated neurodegeneration and premature death

New research at Oregon State University provides evidence for the first time that disruption of circadian rhythms - the biological "clocks" found in many animals - can clearly cause accelerated neurodegeneration, loss of motor function and premature death.

11 Jan 2012

FDA grants 510(k) clearance for Varian's new radiotherapy treatment planning tool

Varian Medical Systems has received FDA 510(k) clearance for a new radiotherapy treatment planning tool designed to work with the company's market leading Eclipse™ treatment planning software to reduce the amount of time needed for planning advanced treatments.

11 Jan 2012

HealthSaaS enters innovative alliance with iMPak for chronic pain management and medication adherence

The iMPak Health Journal for Pain empowers patients to easily record their pain levels before and after their prescribed medication regimen, providing physicians with readily available, useful, patient information.

11 Jan 2012

Care for Asian-American heart attack patients gets better

Care for Asian-American heart attack patients improved between 2003 and 2008, according to a study published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

11 Jan 2012

Tobacco more harmful to lungs than marijuana

A large-scale national study suggests low to moderate use of marijuana is less harmful to users' lungs than exposure to tobacco, even though the two substances contain many of the same components. This comprehensive study, led by UCSF and University of Alabama at Birmingham, collected data from more than 5,000 U.S. adults for more than 20 years.

11 Jan 2012

Physiological impact of hurt feelings

Working up your courage to ask someone to be your Valentine? Science is uncovering the reason why we fear social rejection: Not only does it dash our hopes, it actually puts the brakes on our heart. Specifically, learning that someone doesn't like you triggers a drop in heart rate.

11 Jan 2012

Research identifies several new means to potentially target cancer

Scientists at the University of Leicester have opened up a whole new approach to the therapeutic intervention for a family of anti-cancer drug targets, thanks to a completely new and unexpected finding.

11 Jan 2012

Baro-Therapies introduces portable barometric therapy device for pain, inflammation

Baro-Therapies, Inc. has announced the national launch of The Rejuvenator, a portable barometric therapy device that provides drug-free relief from inflammatory pain and neurological conditions using elevated barometric pressure.

11 Jan 2012

Shire, Janssen enter development and marketing agreement for Resolor

Shire plc, the global specialty biopharmaceutical company, announced today that it has acquired the rights to develop and market Resolor (prucalopride) in the United States (US) in an agreement with Janssen Pharmaceutica N.V.

11 Jan 2012

UCLA researchers identify chemical changes in brains of patients with early-onset Alzheimer's

With a lack of effective treatments for Alzheimer's, most of us would think long and hard about whether we wanted to know years in advance if we were genetically predisposed to develop the disease. For researchers, however, such knowledge is a window into Alzheimer's disease's evolution.

11 Jan 2012

SANUWAVE PACE technology reverses negative effects of ischemic, reperfusion injuries

SANUWAVE Health, Inc., today reported publication of peer-reviewed, preclinical data conducted at Cleveland Clinic that demonstrate the ability of the Company's Pulsed Acoustic Cellular Expression (PACE®) technology to substantially decrease the detrimental effects of microcirculatory injury for certain ischemic (lack of blood flow) and reperfusion (restoration of blood flow) injuries.

11 Jan 2012

Stereotaxis completes 50 clinical procedures with new Niobe ES system to treat cardiac arrhythmias

Stereotaxis, Inc. today announced the completion of the first 50 clinical procedures using the Company's new Niobe ES system to treat patients with a variety of complex cardiac arrhythmias. A majority of the first 50 cases were performed to treat atrial fibrillation (AF), the most common type of cardiac arrhythmia.

11 Jan 2012

Special training for fewer injuries while playing handball

Handball is one of the top four sports, at least as far as the risk of injury is concerned. In particular, the jump shot frequently causes sprained ankles, tears to the ligaments connecting the bones of the foot and the lower leg.

11 Jan 2012

Tesco selects Cancer Research UK as Charity of the Year in 2012

Today, 10 January 2012, Tesco is aiming to raise over £10 million to help Cancer Research UK's work to beat cancer by making Cancer Research UK its Charity of the Year in 2012.

11 Jan 2012

Pulmonx receives CE approval for expanded labeling of Zephyr endobronchial valve

Pulmonx SARL today announced that its European notified body has granted CE approval for expanded labeling of its Zephyr endobronchial valve.

11 Jan 2012

Cognitive performance declines more rapidly as age increases

Increased life expectancy implies fundamental changes in the composition of populations, with a significant rise in the number of elderly people. These changes are likely to have a massive influence on the life of individuals and on society in general.

11 Jan 2012

Medical Condition News

Health Affairs assesses real-world lifestyle interventions to help prevent diabetes

Erlotinib better for treatment of non-small cell lung cancers

Damon Runyon Cancer Research Foundation names 18 new Fellows

Precise diagnostic algorithm for fibrosis in HCV patients reduces need for liver biopsy

Disruption of circadian rhythms cause accelerated neurodegeneration and premature death

FDA grants 510(k) clearance for Varian's new radiotherapy treatment planning tool

HealthSaaS enters innovative alliance with iMPak for chronic pain management and medication adherence

Care for Asian-American heart attack patients gets better

Tobacco more harmful to lungs than marijuana

Physiological impact of hurt feelings

Research identifies several new means to potentially target cancer

Baro-Therapies introduces portable barometric therapy device for pain, inflammation

Shire, Janssen enter development and marketing agreement for Resolor

UCLA researchers identify chemical changes in brains of patients with early-onset Alzheimer's

SANUWAVE PACE technology reverses negative effects of ischemic, reperfusion injuries

Stereotaxis completes 50 clinical procedures with new Niobe ES system to treat cardiac arrhythmias

Special training for fewer injuries while playing handball

Tesco selects Cancer Research UK as Charity of the Year in 2012

Pulmonx receives CE approval for expanded labeling of Zephyr endobronchial valve

Cognitive performance declines more rapidly as age increases

Making Complex Cell Culture Easy and Efficient with AI

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Latest News